Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regeneration

Tissue Engineering - Part A

Volumn 16, Issue 1, 2010, Pages 33-43

  Niemeyer, Philipp ^a   Schönberger, Thomas S ^a   Hahn, Joachim ^b   Kasten, Philip ^c   Fellenberg, Joerg ^d   Suedkamp, Norbert ^a   Mehlhorn, Alexander T ^a   Milz, Stefan ^b   Pearce, Simon ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b AO RESEARCH INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL PROLIFERATION; COLLAGEN; DEFECTS; FLOWCHARTING; HISTOLOGY; RADIATION; RADIOLOGY; STEM CELLS; WOOL;

BONE DEFECT; BONE FORMATION; BONE HEALING; BONE MARROW; BONE REGENERATION; CELL POPULATIONS; CRITICAL SIZE DEFECT; HUMAN CELLS; HUMAN MESENCHYMAL STEM CELLS; IN-SITU HYBRIDIZATION; MESENCHYMAL STEM CELL; MESENCHYMAL TISSUES; MINERALIZED COLLAGEN; REGENERATIVE CAPACITY; TREATMENT GROUP;

CELL CULTURE;

OVIS; OVIS ARIES;

ADULT; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; FEMALE; HUMAN; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SHEEP; TIBIA FRACTURE; XENOGRAFT;

ADULT; ANIMALS; BONE REGENERATION; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; SHEEP; TIBIAL FRACTURES; TRANSPLANTATION, HETEROLOGOUS;

EID: 77049118330     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0190     Document Type: Article

References (39)

1. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. JBJS Am 80, 985, 1998.
2. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
3. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56, 283, 1994.
4. Arinzeh, T.L., Peter, S.J., Archambault, M.P., van den Bos, C., Gordon, S., Kraus, K., Smith, A., and Kadiyala, S. Allo-geneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 85-A, 1927, 2003.
5. Dean, R.M., and Bishop, M.R. Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep 2, 287, 2003.
6. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57, 11, 2003.
7. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30, 42, 2002.
8. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31, 890, 2003.
9. Koc, O.N., Peters, C., Aubourg, P., Raghavan, S., Dyhouse, S., DeGasperi, R., Kolodny, E.H., Yoseph, Y.B., Gerson, S.L., Lazarus, H.M., Caplan, A.I., Watkins, P.A., and Krivit, W. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 27, 1675, 1999.
10. Rasmusson, I., Ringden, O., Sundberg, B., and Le Blanc, K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305, 33, 2005.
11. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., and Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.
12. Grinnemo, K.H., Mansson, A., Dellgren, G., Klingberg, D., Wardell, E., Drvota, V., Tammik, C., Holgersson, J., Ring-den, O., Sylven, C., and Le Blanc, K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127, 1293, 2004.
13. Niemeyer, P., Vohrer, J., Schmal, H., Kasten, P., Fellenberg, J., Suedkamp, N.P., and Mehlhorn, A.T. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy 10, 784, 2008.
14. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O. Treatment of severe acute graft-versus-host disease with third party hap-loidentical mesenchymal stem cells. Lancet 363, 1439, 2004.
15. De Kok, I.J., Peter, S.J., Archambault, M., van den Bos, C., Ka-diyala, S., Aukhil, I., and Cooper, L.F. Investigation of alloge-neic mesenchymal stem cell-based alveolar bone formation: preliminary findings. Clin Oral Implants Res 14, 481, 2003.
16. Poncelet, A.J., Vercruysse, J., Saliez, A., and Gianello, P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83, 783, 2007.
17. Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., and Ga-lipeau, J. Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 106, 4057, 2005.
18. Badillo, A.T., Beggs, K.J., Javazon, E.H., Tebbets, J.C., and Flake, A.W. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant 13, 412, 2007.
19. Saito, T., Kuang, J.Q., Bittira, B., Al-Khaldi, A., and Chiu, R.C. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74, 19, 2002.
20. Croitoru-Lamoury, J., Williams, K.R., Lamoury, F.M., Veas, L.A., Ajami, B., Taylor, R.M., and Brew, B.J. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy 8, 445, 2006.
21. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615, 2001.
22. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
23. Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wir-kner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., and Ho, A.D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33, 1402, 2005.
24. Niemeyer, P., Krause, U., Punzel, M., Fellenberg, J., and Si-mank, H.G. Mesenchymale Stammzellen zum Tissue Engineering von Knochen: 3-D-Kultivierung und Osteogene Differenzierung auf mineralisiertem Kollagen. Z Orthop 141, 712, 2003.
25. Niemeyer, P., Krause, U., Fellenberg, J., Kasten, P., Seck-inger, A., Ho, A.D., and Simank, H.G. Evaluation of mineralized collagen and alpha-tricalcium phosphate as scaffolds for tissue engineering of bone using human mes-enchymal stem cells. Cells Tissues Organs 177, 68, 2004.
26. Schönberger, T., Hahn, J., Kasten, P., Sü dkamp, N.P., Fech-ner, K., Pearce, S., and Niemeyer, P. A novel software-based evalutation method for objective quantification of bone regeneration in experimental bone defects. Eur Cells Mater J 51, 14, 2007.
27. Mosheiff, R., Friedman, A., Friedman, M., and Liebergall, M. Quantification of guided regeneration of weight-bearing bones. Orthopedics 26, 789, 2003.
28. Werntz, J.R., Lane, J.M., Burstein, A.H., Justin, R., Klein, R., and Tomin, E. Qualitative and quantitative analysis of ortho-topic bone regeneration by marrow. J Orthop Res 14, 85, 1996.
29. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mes-enchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
30. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D., and Jorgensen, C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837, 2003.
31. Wang, L., Lu, X.F., Lu, Y.R., Liu, J., Gao, K., Zeng, Y.Z., Li, S.F., Li, Y.P., Cheng, J.Q., Tan, W.D., and Wan, L. Im-munogenicity and immune modulation of osteogenic differentiated mesenchymal stem cells from Banna minipig inbred line. Transplant Proc 38, 2267, 2006.
32. Liechty, K.W., MacKenzie, T.C., Shaaban, A.F., Radu, A., Moseley, A.M., Deans, R., Marshak, D.R., and Flake, A.W. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6, 1282, 2000.
33. Niemeyer, P., Kornacker, M., Mehlhorn, A., Seckinger, A., Vohrer, J., Schmal, H., Kasten, P., Eckstein, V., Sudkamp, N.P., and Krause, U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 13, 111, 2007.
34. Viljanen, V.V., and Lindholm, T.S. Comparison of native xenogeneic and allogeneic bone morphogenetic proteins in the sheep skull defect assay model. Ann Chir Gynaecol 86, 255, 1997.
35. Thielemann, F.W., Spaeth, G., Veihelmann, D., and Schmidt, K. Osteoinduction. Part I: test model and comparative long term observation of allogenic and xenogenic matrix implants. Arch Orthop Trauma Surg 99, 217, 1982.
36. Torricelli, P., Fini, M., Rocca, M., Giavaresi, G., and Giardi-no, R. Xenogenic demineralized bone matrix: osteoinduction and influence of associated skeletal defects in heterotopic bone formation in rats. Int Orthop 23, 178, 1999.
37. Niemeyer, P., Kasten, P., Simank, H.G., Fellenberg, J., Seckinger, A., Kreuz, P.C., Mehlhorn, A., Sudkamp, N.P., and Krause, U. Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation. Cytotherapy 8, 354, 2006.
38. Siddappa, R., Licht, R., van Blitterswijk, C., and de Boer, J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25, 1029, 2007.
39. Mendes, S.C., Tibbe, J.M., Veenhof, M., Both, S., Oner, F.C., van Blitterswijk, C.A., and de Bruijn, J.D. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15, 1123, 2004.